Xenon Pharmaceuticals (XENE) Tops Q2 EPS by 3c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q2 EPS of ($1.11), $0.03 better than the analyst estimate of ($1.14).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• Musalem: strong growth and investment influencing bond market - CNBC
• ACRES Commercial Realty says labor dispute is hindering hotel sale
• Deere shares climb as fiscal Q3 earnings and revenue top estimates